1. Home
  2. NVO vs COST Comparison

NVO vs COST Comparison

Compare NVO & COST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • COST
  • Stock Information
  • Founded
  • NVO 1923
  • COST 1976
  • Country
  • NVO Denmark
  • COST United States
  • Employees
  • NVO N/A
  • COST N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • COST Department/Specialty Retail Stores
  • Sector
  • NVO Health Care
  • COST Consumer Discretionary
  • Exchange
  • NVO Nasdaq
  • COST Nasdaq
  • Market Cap
  • NVO 278.0B
  • COST 436.9B
  • IPO Year
  • NVO N/A
  • COST 1993
  • Fundamental
  • Price
  • NVO $68.96
  • COST $980.91
  • Analyst Decision
  • NVO Buy
  • COST Buy
  • Analyst Count
  • NVO 3
  • COST 26
  • Target Price
  • NVO $112.00
  • COST $1,047.54
  • AVG Volume (30 Days)
  • NVO 7.7M
  • COST 2.1M
  • Earning Date
  • NVO 08-06-2025
  • COST 05-29-2025
  • Dividend Yield
  • NVO 1.71%
  • COST 0.53%
  • EPS Growth
  • NVO 17.93
  • COST 9.30
  • EPS
  • NVO 3.40
  • COST 17.63
  • Revenue
  • NVO $43,922,211,349.00
  • COST $268,776,000,000.00
  • Revenue This Year
  • NVO $18.59
  • COST $10.14
  • Revenue Next Year
  • NVO $15.61
  • COST $7.56
  • P/E Ratio
  • NVO $20.27
  • COST $55.66
  • Revenue Growth
  • NVO 24.11
  • COST 5.95
  • 52 Week Low
  • NVO $57.00
  • COST $793.00
  • 52 Week High
  • NVO $143.49
  • COST $1,078.24
  • Technical
  • Relative Strength Index (RSI)
  • NVO 44.64
  • COST 45.20
  • Support Level
  • NVO $68.65
  • COST $965.70
  • Resistance Level
  • NVO $71.75
  • COST $995.87
  • Average True Range (ATR)
  • NVO 1.38
  • COST 14.22
  • MACD
  • NVO -0.23
  • COST -0.75
  • Stochastic Oscillator
  • NVO 42.83
  • COST 37.89

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About COST Costco Wholesale Corporation

Costco operates a membership-based, no-frills retail model predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given its frugal cost structure, the firm is able to price its merchandise below that of competing retailers, driving high sales volume per warehouse and generating strong profits on thin margins. Costco operates over 600 warehouses in the United States and has over 60% share in the domestic warehouse club industry. Internationally, Costco operates about 280 warehouses, primarily in Canada, Mexico, Japan, and the UK.

Share on Social Networks: